Aromasin 25 Odin Pharmaceuticals

£150.00

Aromasin 25 Odin Pharmaceuticals is a steroidal aromatase inhibitor containing exemestane for research into hormone pathway modulation. Available as 25mg tablets for in-vitro laboratory studies only.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Aromasin 25 Odin Pharmaceuticals
Aromasin 25 Odin Pharmaceuticals
£150.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications

Aromasin 25 is a steroidal aromatase inhibitor manufactured by Odin Pharmaceuticals, containing 25mg exemestane per tablet. This pharmaceutical-grade compound represents a valuable research tool for investigating estrogen biosynthesis pathways and aromatase enzyme inhibition in controlled laboratory environments. Research scientists at Stroid UK Shop utilise this compound to examine hormone regulation mechanisms and metabolic pathways in cellular models.

Molecular Profile and Mechanism

Exemestane functions as an irreversible, steroidal aromatase inhibitor that covalently binds to the aromatase enzyme complex. In research applications, scientists examine its mechanism of permanently inactivating cytochrome P450 19A1 (CYP19A1), the enzyme responsible for converting androgens to estrogens. Laboratory studies investigate how this compound differs from reversible inhibitors, providing unique research opportunities for understanding estrogen-dependent biological processes. Researchers studying aromasin aromatase inhibitors frequently compare exemestane’s binding kinetics with other compounds in this therapeutic class.

Laboratory Research Specifications

Aromasin 25 Technical Parameters
Parameter Specification
Active Compound Exemestane
Strength 25mg per tablet
Manufacturer Odin Pharmaceuticals
CAS Number 107868-30-4
Molecular Formula C₂₀H₂₄O₂
Molecular Weight 296.40 g/mol
Storage Conditions Room temperature, dry environment

Research laboratories investigating hormone modulation often compare exemestane studies with related compounds available through SARMs research and peptide research programmes to understand comprehensive endocrine system interactions.

Compliance and Research Use

This product is supplied exclusively for in-vitro laboratory research applications. Aromasin 25 Odin Pharmaceuticals is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional review board protocols and applicable laboratory safety regulations when handling this compound.

Related